Berberine
Berberine may lower glucose while hexarelin can alter GH-axis glucose regulation.
Recommendation: Avoid unsupervised stacking and monitor glucose in any medically supervised context.
Peptide ·Insufficient evidence ·Reviewed May 2026
Hexarelin is a potent synthetic growth hormone secretagogue in the GHRP class that activates ghrelin or growth hormone secretagogue receptors and can raise GH, cortisol, and prolactin. It is not FDA-approved for human use, not approved for anti-aging or body composition, and long-term safety data are limited. Concerns include desensitization, glucose intolerance, edema, cortisol or prolactin effects, pituitary-axis disruption, injection risks, and WADA-prohibited status.
The bottom line
Evidence rating insufficient. Most-documented uses: acutely stimulates gh release in research settings, used to study gh, cortisol, and prolactin responses, preclinical cardioprotective mechanisms have been explored. 3 sources indexed (1995–2025), with 3 interaction records on file.
Core mechanism
Hexarelin activates GHS-R1a receptors in the pituitary and hypothalamus, producing a strong GH pulse and secondary IGF-1 effects if repeated stimulation is effective. Compared with more selective secretagogues, it is more likely to raise ACTH, cortisol, and prolactin. Some preclinical work also links hexarelin to CD36 and cardiometabolic pathways, but these findings do not establish safe human wellness use.3,1
Peptide use in studies is parenteral. Research-grade injection is unsafe.2
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Research peptide vial.
Research-market pricing is not a recommendation for human use. Updated 2026-06-04.
Dose: Protocol-specific; no approved consumer dose2
Timing: Research protocol only
Acute hormone response is not a clinical benefit endpoint.
Dose: No FDA-approved dose
Timing: Not applicable
Long-term safety and efficacy are not established.
Dose: No approved dose
Timing: Not applicable
Cardioprotective claims are largely preclinical and not a reason for human self-use.
What to test, the optimal window inside the conventional range, and how long a response takes.
May increase with GH-axis stimulation, but response and safety are not established.2
Do not use for unsupervised peptide self-treatment.
May increase acutely in endocrine studies.2
Evaluate adrenal symptoms through an endocrinologist.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Acutely stimulates GH, but not approved for IGF-1 treatment.2
Requires endocrine diagnosis.
Performance claims are extrapolated from GH-axis activation.
WADA-prohibited and not FDA-approved.
GH secretagogues may worsen edema; this is a risk rather than a benefit.1
Edema needs medical evaluation.
Berberine may lower glucose while hexarelin can alter GH-axis glucose regulation.
Recommendation: Avoid unsupervised stacking and monitor glucose in any medically supervised context.
Alpha-lipoic acid can affect glucose handling while hexarelin may worsen glucose tolerance.
Recommendation: Use clinician-guided glucose monitoring if exposure occurs.
Creatine-related water weight can mask edema from GH-axis stimulation.
Recommendation: Monitor swelling, blood pressure, numbness, and joint symptoms.
Numbered references. Citations throughout the page link here.
GH secretagogues including hexarelin are prohibited for athletes.
Hexarelin induced dose-related endocrine responses including GH, cortisol, and prolactin.
Naloxone did not block hexarelin-induced hormone changes, supporting a non-opioid GHRP mechanism.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.